Cell Signaling Pathways, Receptors, and Transduction Mechanisms

Principles of Cell Communication and Signaling Cascades

• Biological Necessity of Cellular Communication:
  • Cells must continuously receive, process, and adapt to incoming signals from their extracellular environment to coordinate metabolic activity, growth, differentiation, and tissue architecture.
  • Cellular signaling underlies evolutionary adaptation; even unicellular organisms such as budding yeast (Saccharomyces cerevisiae) communicate their mating type via secreted mating factors, undergoing polarized morphological changes (forming mating projections or "shmoos") toward a mating partner.

• Basic Architecture of a Signal Transduction Pathway:
  • Extracellular Signal Molecule: The primary ligand (e.g., peptide, steroid, amino acid derivative, gas, or fatty acid derivative) released by an initiating cell.
  • Receptor Protein: A specialized protein—typically spanning the plasma membrane—that specifically recognizes and binds the extracellular signal molecule.
  • Intracellular Signaling Molecules: A cascade of downstream biochemical messengers (kinases, phosphatases, small GTP-binding proteins, and second messengers) that transmit and process the message inside the cell.
  • Effector Proteins: Direct regulatory targets at the terminus of the signaling cascade that alter cell physiology.
  • Target Cell Responses:
  • Metabolic enzymes $\rightarrow$ altered metabolism.
  • Cytoskeletal proteins $\rightarrow$ altered cell shape, structure, or movement.
  • Transcription regulators $\rightarrow$ altered patterns of gene expression.

Modes of Extracellular Signaling over Variable Distances

• Endocrine Signaling:

  • Specialized endocrine cells secrete signaling molecules called hormones directly into the bloodstream.
  • The vascular system carries hormones over long distances throughout the whole body to reach distant target cells possessing specific receptors.

• Paracrine Signaling:

  • Signaling cells synthesize and release local mediators into the surrounding extracellular fluid.
  • Molecules remain localized and act exclusively on neighboring target cells in the immediate vicinity.
  • Autocrine Signaling: A specialized sub-form of paracrine signaling wherein the emitting cell possesses receptors for its own secreted mediator, thereby responding directly to its own signal.

• Synaptic Signaling:

  • Dedicated to rapid, long-range, and highly targeted intercellular communication in the nervous system.
  • Electrical action potentials propagate down a specialized axonal projection of a neuron.
  • Arrival at the nerve terminal stimulates exocytosis of chemical neurotransmitters across a narrow junction (the synapse) to bind receptors on the membrane of an adjacent postsynaptic target cell.

• Contact-Dependent Signaling (Juxtacrine Signaling):

  • Requires direct physical contact between the interacting cells.
  • The signaling molecule remains anchored in the plasma membrane of the signaling cell and engages receptor proteins physically embedded within the plasma membrane of the adjacent target cell without any secretion of a soluble messenger.

Specificity, Signal Combinations, and Cellular Fate Decisions

• Differential Target Cell Responses to a Single Extracellular Signal:
  • The functional outcome elicited by a ligand is not strictly determined by the chemical identity of the ligand alone, but by the receptor type and intracellular machinery present inside the target cell.
  • Acetylcholine ($\text{CH}_3\text{COOCH}_2\text{CH}_2\text{N}^+(\text{CH}_3)_3$) serves as a primary example:
  • Heart Pacemaker Cells: Express muscarinic G-protein-coupled receptors (GPCRs); acetylcholine binding activates a $G_i$ signaling pathway that opens $\text{K}^+$ channels, hyperpolarizing the cell membrane and resulting in a decreased rate of firing.
  • Salivary Gland Cells: Express muscarinic GPCRs linked to $G_q$; acetylcholine binding triggers inositol phospholipid hydrolysis and intracellular $\text{Ca}^{2+}$ release, leading to salivary secretion.
  • Skeletal Muscle Cells: Express nicotinic acetylcholine receptors (ligand-gated ion channels); acetylcholine binding allows $\text{Na}^+$ influx, membrane depolarization, and stimulates muscle contraction.

• Combinatorial Signaling Dictates Cell Fate:
  • Animal cells in vivo are bathed in complex mixtures of extracellular signal molecules that act synergistically.
  • Individual cells selectively interpret particular combinations of signals:
  • Survive: Driven by basal survival signal combinations (e.g., signals A, B, and C).
  • Grow + Divide: Stimulated when survival signals are supplemented with specific growth factors and mitogens (signals A, B, C, D, and E).
  • Differentiate: Induced when survival signals are accompanied by cell differentiation signals (signals A, B, C, F, and G).
  • Apoptosis (Cell Death): Deprivation of essential survival signals automatically triggers an intracellular programmed cell death pathway, leading to an apoptotic cell.

Kinetics of Cellular Responses and Temporal Dynamics

• Response Velocity: Fast Versus Slow Cascades:
  • Fast Responses ($<\text{seconds to minutes}$):
  • Operates by altering the covalent modification or conformation of proteins already present in the cytoplasm.
  • Involves rapid molecular switches such as protein phosphorylation/dephosphorylation or direct allosteric modulation of enzymes and cytoskeletal assemblies.
  • Slow Responses ($\text{minutes to hours}$):
  • Requires signaling intermediates to translocate to the nucleus, recruit transcriptional machinery, and alter gene expression.
  • Involves de novo transcription of mRNA followed by translation and post-translational maturation of new protein products.

• Pharmacological Modulation of Signal Duration:
  • The biological duration of a signal dictates the magnitude of cellular work performed.
  • Prolonging the lifetime of a signaling messenger directly prolongs downstream physiological actions.
  • Nitric Oxide ($\text{NO}$) and Sildenafil (Viagra) Mechanism:
  • Sexual stimulation drives neuronal and endothelial release of nitric oxide ($\text{NO}$).
  • $\text{NO}$ diffuses into vascular smooth muscle cells and stimulates guanylyl cyclase, converting $\text{GTP}$ into cyclic guanosine monophosphate ($\text{cGMP}$).
  • Elevated $\text{cGMP}$ induces smooth muscle relaxation, yielding local vasodilation and increased blood flow that generates penile erection.
  • Under normal physiology, the enzyme phosphodiesterase type 5 (PDE5) terminates this response by degrading $\text{cGMP}$ into $\text{GMP}$.
  • Sildenafil acts as a competitive inhibitor of PDE5, preventing $\text{cGMP}$ breakdown and maintaining persistent vasodilation and erection.

Mechanisms of Intracellular Signal Processing and Molecular Switches

• Functional Operations of Intracellular Cascades:
  • Primary Transduction: The ligand-bound cell-surface receptor converts an external extracellular stimulus into an internal chemical signal across the plasma membrane.
  • Relay: The message is transferred sequentially from one intracellular signaling molecule to the next, often mediated by physical scaffolding proteins that hold interacting kinases and substrates together.
  • Transduce and Amplify: The incoming signal is enzymatically transduced into high-concentration bursts of small intracellular messenger molecules (second messengers), amplifying a minuscule initial stimulus into thousands of downstream molecules.
  • Integrate: Separate signaling pathways converge on a single nodal protein, which functions as a molecular computation node requiring input from two or more pathways before firing.
  • Distribute: The processed signal branches out to multiple downstream targets (metabolic enzymes, cytoskeletal proteins, transcription factors) to evoke coordinate phenotypic adjustments.

• Two Major Classes of Molecular Switches:
  • Signaling by Protein Phosphorylation:
  • Regulated by opposing enzyme pairs: Protein Kinase and Protein Phosphatase.
  • Protein kinase covalently transfers a terminal phosphate group from $\text{ATP}$ onto specific amino acid hydroxyl groups (typically serine, threonine, or tyrosine) of the target protein, yielding $\text{ADP}$ and turning the target "ON".
  • Protein phosphatase hydrolyzes the phosphate moiety, releasing inorganic phosphate ($\text{P}_i$) and reverting the target back to its inactive "OFF" state.
  • Signaling by GTP-Binding Proteins:
  • Controlled by the binding and enzymatic hydrolysis of guanosine triphosphate ($\text{GTP}$).
  • In the inactive "OFF" state, the protein is tightly bound to guanosine diphosphate ($\text{GDP}$).
  • An incoming activation signal induces $\text{GDP}$ release and subsequent binding of $\text{GTP}$, inducing conformational remodeling into the active "ON" state.
  • The protein possesses intrinsic GTPase catalytic activity; it hydrolyzes $\text{GTP}$ to $\text{GDP} + \text{P}_i$, automatically switching itself off after a defined temporal interval.

• Feedback Regulation and Homeostasis:
  • Cascades are dynamically tuned by internal feedback loops:
  • Positive Feedback: A downstream signaling intermediate ($Y$) acts back to stimulate an upstream node ($X$), generating an all-or-none, irreversible switch-like biological activation.
  • Negative Feedback: A downstream intermediate ($Y$) acts back to inhibit an upstream node ($X$), creating adaptive dampening, self-limiting signal attenuation, or periodic oscillatory behavior.

• Maintenance of Biological Set-Points:
  • Negative feedback signaling networks sustain biological homeostasis across organs and systems, maintaining constant set-points (e.g., body temperature, body weight, and baseline receptor sensitivity).
  • In metabolic homeostatic control, fat stores produce adiposity signals (leptin and insulin) that act on the central nervous system (CNS):
  • Inhibit anabolic circuits (NPY/AGRP), decreasing food intake and increasing energy conservation.
  • Stimulate catabolic circuits (POMC/CART), suppressing food intake and elevating energy expenditure via increased metabolic rate and physical activity.

Receptor Taxonomy and Pharmacology of Cell-Surface Targets

• Major Classes of Receptors:
  • Cell-Surface Receptors: Required for large, hydrophilic, or charged signaling molecules unable to cross the hydrophobic core of the plasma membrane:
  1. Ion-Channel-Coupled Receptors (Transmitter-Gated Ion Channels): Binding of ligand opens or closes a transmembrane aqueous pore, permitting selective ion flux ($\text{Na}^+$, $\text{K}^+$, $\text{Ca}^{2+}$, or $\text{Cl}^-$) down electrochemical gradients, altering membrane potential.
  2. G-Protein-Coupled Receptors (GPCRs): Ligand binding alters the conformation of a seven-pass transmembrane protein, activating a membrane-associated trimeric GTP-binding protein (G protein) that subsequently regulates membrane-bound enzymes or ion channels.
  3. Enzyme-Coupled Receptors: Transmembrane proteins that either operate directly as catalytic enzymes (possessing intrinsic intracellular kinase domains) or form stable complexes with intracellular catalytic enzymes.
  • Intracellular Receptors (4th Class):
  • Located inside the cytosol or nucleus.
  • Bind small, hydrophobic signaling molecules (such as steroid hormones, thyroid hormones, and retinoids) that diffuse freely across the hydrophobic plasma membrane bilayer.

• Exogenous Substances and Pharmacological Action on Receptors:
  • Exogenous drugs and natural toxins exert profound effects because their chemical structures mimic endogenous physiological ligands, acting as agonists (stimulators) or antagonists (blockers).

G-Protein-Coupled Receptors (GPCRs): Structural Architecture and Activation Cycles

• Overview and Prominence of GPCRs:

  • Represents the largest, most structurally conserved superfamily of cell-surface receptors in eukaryotes.
  • Encompasses more than $700$ distinct members in the human genome; mice have over $1000$ GPCR genes devoted exclusively to olfaction.
  • Many GPCRs remain classified as "orphan receptors" because their endogenous ligands have not yet been identified.
  • Targets for approximately $50\%$ of all modern therapeutic pharmaceuticals.
  • Evolutionary origins are ancient, with structural counterparts operating in microorganisms (e.g., bacteriorhodopsin).
  • The 2012 Nobel Prize in Chemistry was awarded to Brian Kobilka and Robert Lefkowitz for landmark discoveries revealing the structural and biochemical operation of GPCRs.

• Structural Conformation of GPCRs:

  • Consists of a single polypeptide chain comprising seven transmembrane $\alpha$-helices spanning the lipid bilayer (seven-pass transmembrane proteins).
  • Possesses an extracellular N-terminus and interstitial loops forming the ligand-binding pocket.
  • Possesses an intracellular C-terminus and cytosolic loops that interface directly with heterotrimeric G proteins.

• Heterotrimeric G-Protein Subunit Architecture:

  • Composed of three distinct protein subunits: $\alpha$, $\beta$, and $\gamma$.
  • The $G_\alpha$ and $G_\gamma$ subunits are covalently modified by lipid anchors, tethering them to the cytosolic leaflet of the plasma membrane.
  • In the basal, inactive state, the $G_\alpha$ subunit binds $\text{GDP}$ and remains tightly complexed with the $G_{\beta\gamma}$ heterodimer.

• Sequential Activation and Hydrolysis Cycle:

  • Step 1: Agonist Binding: Extracellular ligand binds the GPCR, inducing a conformational change transmitted across the transmembrane core to the cytosolic loops.
  • Step 2: Guanine Nucleotide Exchange: The activated GPCR functions as a guanine nucleotide exchange factor (GEF), altering the $G_\alpha$ binding pocket so that bound $\text{GDP}$ dissociates and is rapidly replaced by high-affinity $\text{GTP}$.
  • Step 3: Subunit Dissociation: $\text{GTP}$ binding induces an active conformation in $G_\alpha$, driving its dissociation from the receptor and triggering physical separation of the active $G_\alpha\text{-GTP}$ monomer from the active $G_{\beta\gamma}$ dimer.
  • Step 4: Target Activation: Both $G_\alpha\text{-GTP}$ and free $G_{\beta\gamma}$ diffuse along the membrane plane to bind and activate target proteins (enzymes or ion channels).
  • Step 5: Amplification by Receptor: As long as the agonist remains bound, a single GPCR can sequentially bind and activate hundreds of individual G-protein complexes.
  • Step 6: Intrinsic GTP Hydrolysis: The $G_\alpha$ subunit possesses an internal GTPase domain that hydrolyzes bound $\text{GTP}$ to $\text{GDP} + \text{P}_i$. This serves as an internal molecular timer, inactivating $G_\alpha$.
  • Step 7: Reassembly: Upon $\text{GTP}$ hydrolysis, $G_\alpha\text{-GDP}$ dissociates from its target enzyme and reassociates with the $G_{\beta\gamma}$ complex, regenerating the inactive heterotrimer.

• Direct Regulation of Ion Channels by G-Protein Subunits:
  • G proteins can directly modulate ion permeability without utilizing second messengers.
  • Regulation of Pacemaker Potassium Channels:
  • Acetylcholine released onto heart pacemaker cells binds a muscarinic GPCR.
  • The activated GPCR stimulates a $G_i$ protein; the dissociated active $G_{\beta\gamma}$ complex binds directly to the intracellular surface of a closed $\text{K}^+$ channel in the plasma membrane.
  • This interaction forces the $\text{K}^+$ channel open, allowing $\text{K}^+$ ions to flow out of the cell.
  • The outward current hyperpolarizes the pacemaker membrane, inhibiting electrical excitability and decreasing the frequency of heart contractions.
  • Hydrolysis of $\text{GTP}$ by $G_\alpha$ terminates the interaction, allowing the $\text{K}^+$ channel to close.

GPCR Desensitization, Arrestin Signaling, and Receptor Downregulation

• Mechanisms of Desensitization and Homeostatic Adaptation:
  • Prolonged or high-concentration agonist exposure drives cells to desensitize their receptors to prevent excitotoxicity or metabolic exhaustion.
  • Step 1: Receptor Phosphorylation: Prolonged GPCR activation triggers G-protein-coupled receptor kinases (GRKs) to phosphorylate specific serine and threonine residues located on the cytosolic C-terminal tail of the receptor.
  • Step 2: $\beta$-Arrestin Binding: Phosphorylation creates high-affinity docking sites for the cytosolic scaffolding protein $\beta$-arrestin (B-arrestin). Binding of $\beta$-arrestin physically uncouples the receptor from heterotrimeric G proteins, halting downstream G-protein signaling (desensitization).
  • Step 3: Internalization (Endocytosis): $\beta$-arrestin recruits clathrin and endocytic machinery, promoting receptor invagination into clathrin-coated pits and subsequent endocytosis into endosomes.
  • Step 4: Endosomal Fate: Internalized receptors are sorted into one of two pathways:
  • Recycling: Dephosphorylation in the endosome and return to the plasma membrane (resensitization).
  • Degradation: Delivery to lysosomes for proteolytic degradation (downregulation).

• Pharmacological Consequences of Desensitization:
  • Drug Tolerance: Progressive loss of drug responsiveness over repeated administrations, requiring increasing doses to achieve the same clinical effect (e.g., chronic opioid use).
  • Drug Dependence: Cellular rewiring and loss of surface receptors that disrupt baseline homeostasis when the drug is withdrawn.
  • $\beta$-Arrestin-Mediated Signaling: $\beta$-arrestin is not merely an off-switch; it functions as an independent signaling platform that activates MAP kinase cascades and other non-G-protein pathways.

G-Protein Classes, Toxins, and Second Messenger Systems

• Taxonomy of Mammalian G Proteins:

  • Approximately $20$ distinct $G_\alpha$ subtypes exist in mammals, categorized into four primary functional classes:
  • $G_s$ (Stimulatory): Stimulates adenylyl cyclase, dramatically elevating cyclic AMP ($\text{cAMP}$).
  • $G_i$ (Inhibitory): Inhibits adenylyl cyclase, decreasing $\text{cAMP}$; activates ion channels and phosphodiesterases.
  • $G_q$: Activates phospholipase C-beta (PLC), triggering inositol phospholipid breakdown into $\text{IP}_3$ and $\text{DAG}$, elevating cytosolic $\text{Ca}^{2+}$.
  • $G_{12/13}$: Regulates actin cytoskeletal dynamics and cell migration via Rho GTPase activation.
  • $G_o$, $G_{\text{olf}}$: Specialized classes mediating sensory perception, including olfactory signal transduction ($G_{\text{olf}}$).

• Bacterial Toxins Targeting Heterotrimeric G Proteins:

  • Cholera Toxin (from Vibrio cholerae):
  • An enzyme that chemically modifies the $G_{s\alpha}$ subunit via ADP-ribosylation, preventing $G_{s\alpha}$ from hydrolyzing bound $\text{GTP}$.
  • Locks $G_{s\alpha}$ in an irreversibly active state, continuously stimulating adenylyl cyclase.
  • In the gut epithelium, massive overproduction of $\text{cAMP}$ triggers continuous efflux of $\text{Cl}^-$ and water into the intestinal lumen, causing lethal watery diarrhea and dehydration.
  • Pertussis Toxin (from Bordetella pertussis):
  • An enzyme that ADP-ribosylates the $G_{i\alpha}$ subunit, trapping it in an inactive $\text{GDP}$-bound conformation.
  • Prevents $G_i$ from inhibiting adenylyl cyclase, keeping cyclase overactive and generating the paroxysmal coughing fits characteristic of whooping cough.

• The Cyclic AMP ($\text{cAMP}$) Signaling Pathway:

  • Synthesis and Degradation Chemistry:
  • Adenylyl Cyclase: A multipass transmembrane enzyme that converts $\text{ATP}$ into the cyclic nucleotide secondary messenger cyclic adenosine monophosphate ($\text{cAMP}$) with the release of pyrophosphate ($\text{PP}_i$).
  • Cyclic AMP Phosphodiesterase: Continuously degrades $\text{cAMP}$ via hydrolytic cleavage of the cyclic phosphate diester bond, producing inactive adenosine 5'-monophosphate ($\text{AMP}$).

• Protein Kinase A (PKA) Activation:
  • $\text{cAMP}$ is water-soluble and rapidly diffuses across the cytoplasm.
  • Its primary downstream target is Protein Kinase A (PKA), a serine/threonine protein kinase.
  • In the inactive state, PKA is a tetramer of two catalytic subunits bound to two regulatory subunits.
  • Binding of $\text{cAMP}$ to the regulatory subunits induces a conformational change that releases the active catalytic subunits to phosphorylate target serine and threonine residues.

• Fast $\text{cAMP}$ Response: Skeletal Muscle Glycogenolysis:
  • Adrenaline binds an adrenergic GPCR on skeletal muscle cells.
  • Active $G_s$ stimulates adenylyl cyclase $\rightarrow$ rapid synthesis of $\text{cAMP}$.
  • $\text{cAMP}$ activates PKA.
  • Active PKA phosphorylates and activates phosphorylase kinase utilizing $\text{ATP}$.
  • Active phosphorylase kinase phosphorylates and activates glycogen phosphorylase utilizing $\text{ATP}$.
  • Active glycogen phosphorylase degrades stored glycogen into glucose 1-phosphate for immediate energy utilization.
  • Kinetics: Entire cascade occurs within seconds and requires no de novo transcription.

• Slow $\text{cAMP}$ Response: Transcriptional Gene Activation:
  • Prolonged elevations in $\text{cAMP}$ release active PKA catalytic subunits that diffuse through nuclear pores into the cell nucleus.
  • In the nucleus, PKA phosphorylates specific transcription factors (e.g., CREB, cyclic AMP response element-binding protein).
  • Phosphorylated transcription regulators bind consensus promoter regions on target genes, recruiting coactivators to initiate mRNA transcription.
  • Kinetics: Occurs over minutes to hours, modulating long-term metabolic adaptations and memory consolidation.

• The Inositol Phospholipid (Phospholipase C) Pathway:
  • Enzymatic Cleavage by PLC:
  • An extracellular signal activates a GPCR coupled to a $G_q$ protein.
  • The active $G_{q\alpha}$ subunit activates the membrane-bound enzyme Phospholipase C (PLC).
  • PLC cleaves a specialized inner-leaflet membrane lipid, phosphatidylinositol 4,5-bisphosphate ($\text{PIP}_2$), into two secondary messengers: Inositol 1,4,5-trisphosphate ($\text{IP}_3$) and Diacylglycerol (DAG).
  • Bifurcated Downstream Signaling:
  • $\text{IP}_3$ Pathway: $\text{IP}_3$ is a water-soluble phosphorylated sugar that diffuses into the cytosol and binds to ligand-gated $\text{IP}_3$-sensitive $\text{Ca}^{2+}$ channels on the endoplasmic reticulum (ER) membrane. This releases stored $\text{Ca}^{2+}$ ions into the cytosol, raising the cytosolic free $\text{Ca}^{2+}$ concentration.
  • DAG and Protein Kinase C (PKC) Pathway: DAG remains embedded in the hydrophobic plasma membrane. Free cytosolic $\text{Ca}^{2+}$ recruits the cytosolic enzyme Protein Kinase C (PKC) to the membrane, where it binds DAG. Fully activated PKC then phosphorylates specific target proteins to regulate proliferation, differentiation, and secretory outputs.

• Calcium as a Ubiquitous Intracellular Messenger:
  • Resting cytosolic free $\text{Ca}^{2+}$ concentration is maintained at extremely low levels ($\approx 10^{-7}\,\text{M}$) relative to the extracellular fluid and ER lumen ($\approx 10^{-3}\,\text{M}$) via active $\text{Ca}^{2+}$ pumps.
  • Sudden opening of $\text{Ca}^{2+}$ channels drives massive, rapid influx down its steep electrochemical gradient.
  • Egg Fertilization: Penetration of a starfish egg by a sperm triggers a dramatic, self-propagating wave of cytoplasmic $\text{Ca}^{2+}$ sweeping across the egg from the point of entry within $40\,\text{seconds}$, inducing the cortical reaction to block polyspermy and kickstarting embryonic cell division.

• Calmodulin and CaM-Kinases:
  • $\text{Ca}^{2+}$ mediates effects by binding to calcium-sensing sensor proteins such as calmodulin.
  • Calmodulin contains four EF-hand $\text{Ca}^{2+}$-binding pockets separated by a flexible, $2\,\text{nm}$ central $\alpha$-helix.
  • When saturated with $\text{Ca}^{2+}$, calmodulin undergoes a conformational shift, bending its central helix to wrap tightly around target enzymes, prominently activating $\text{Ca}^{2+}/\text{calmodulin}$-dependent protein kinases (CaM-kinases).

Visual Signal Transduction: High Sensitivity, Amplification, and Adaptation

• Rod Photoreceptor Cell Structure:
  • Photoreception occurs within specialized rod photoreceptor cells in the retina.
  • Structural Components:
  • Outer Segment: Packed with stacks of internal photoreceptive membrane discs containing the GPCR photopigment rhodopsin.
  • Inner Segment: Packed with metabolic mitochondria and biosynthetic machinery.
  • Nuclear Region: Contains the cell nucleus.
  • Synaptic Region: Basal terminal (scale $\approx 2\,\mu\text{m}$) that steadily secretes neurotransmitters onto bipolar interneurons in the dark.

• Quantitative Cascade of Visual Amplification:
  • The vertebrate visual cascade represents an extraordinary example of speed, single-photon sensitivity, and enzyme amplification:
  1. Photon Capture: Exactly $1$ rhodopsin molecule absorbs $1$ photon of light.
  2. G-Protein Activation: The photoactivated rhodopsin interacts with and activates approximately $500$ molecules of the specialized trimeric G protein transducin ($G_t$).
  3. Effector Enzyme Activation: Each transducin $G_{t\alpha}$ subunit activates a cyclic GMP phosphodiesterase, yielding $500$ active $\text{cGMP}$ phosphodiesterase enzyme complexes.
  4. Hydrolysis of Second Messenger: The active phosphodiesterases hydrolyze approximately $10^5$ molecules of cyclic GMP ($\text{cGMP}$) into $\text{GMP}$.
  5. Channel Gating: Fall in local $\text{cGMP}$ concentration causes cyclic-nucleotide-gated channels to dissociate from $\text{cGMP}$, closing approximately $250$ cation channels in the plasma membrane.
  6. Cation Blockade: Approximately $10^6$ to $10^7$ $\text{Na}^+$ ions per second are prevented from entering the photoreceptor cell over a duration of $\approx 1\,\text{second}$.
  7. Membrane Hyperpolarization: The blockade alters the resting membrane potential by $1\,\text{mV}$.
  8. Synaptic Output: Membrane hyperpolarization decreases the tonic release of inhibitory neurotransmitter at the synapse, relaying an electrical nerve impulse to the optic nerve and brain.

Enzyme-Coupled Receptors: Receptor Tyrosine Kinases (RTKs) and the MAP-Kinase Cascade

• Receptor Tyrosine Kinase (RTK) Architecture and Activation:
  • Receptor Tyrosine Kinases (RTKs) represent the largest class of enzyme-coupled receptors, possessing a single transmembrane $\alpha$-helix, an extracellular ligand-binding domain, and an intracellular tyrosine kinase catalytic domain.
  • Activation Mechanism:
  • Signal molecules typically present as biological dimers.
  • Binding of a dimeric signal cross-links two adjacent RTK monomers into a physical receptor dimer.
  • Dimerization brings their intracellular tyrosine kinase domains into direct contact, stimulating mutual trans-autophosphorylation on specific tyrosine residues.
  • Phosphorylated tyrosines act as high-affinity docking sites for intracellular signaling proteins possessing specialized binding modules, such as SH2 domains (Src homology 2) or PTB domains (phosphotyrosine-binding).

• Ras Activation via Adaptor Complexes:
  • Ras: A monomeric GTP-binding protein (small GTPase) anchored to the cytosolic face of the plasma membrane by a prenyl lipid tail.
  • Recruitment Mechanism:
  • Phosphorylated RTK binds an SH2-containing adaptor protein (e.g., Grb2).
  • The adaptor recruits a Ras-GEF (guanine nucleotide exchange factor, e.g., Sos).
  • Ras-GEF forces membrane-anchored inactive Ras to release $\text{GDP}$ and bind $\text{GTP}$.
  • Activated Ras-GTP initiates onward downstream signaling cascades.

• The MAP-Kinase (Mitogen-Activated Protein Kinase) Signaling Module:
  • Ras conveys proliferative and differentiation signals by triggering a three-tiered protein kinase phosphorylation cascade:
  • MAP Kinase Kinase Kinase (MAPKKK / Raf): Recruited and activated at the plasma membrane by active Ras-GTP.
  • MAP Kinase Kinase (MAPKK / Mek): Phosphorylated and activated by MAPKKK using $\text{ATP}$.
  • MAP Kinase (MAPK / Erk): Phosphorylated on both threonine and tyrosine residues by MAPKK using $\text{ATP}$.
  • Effector Phosphorylation and Responses:
  • Active MAP kinase phosphorylates numerous downstream effector proteins:
    • Cytosolic Proteins (Protein X, Protein Y): Immediate alterations in enzymatic and protein activities.
    • Transcription Regulators (Regulator A, Regulator B): Translocate into the nucleus to drive the transcription of early-response genes regulating cell proliferation, survival, and differentiation.